SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,516,000 | +15.1% | 23,078 | -0.1% | 0.02% | +9.1% |
Q2 2020 | $3,925,000 | +92.0% | 23,099 | +30.4% | 0.02% | +57.1% |
Q1 2020 | $2,044,000 | +10.5% | 17,713 | +9.4% | 0.01% | +40.0% |
Q4 2019 | $1,850,000 | +33.8% | 16,194 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $1,383,000 | +23.4% | 16,194 | 0.0% | 0.01% | +14.3% |
Q2 2019 | $1,121,000 | -5.5% | 16,194 | 0.0% | 0.01% | -12.5% |
Q1 2019 | $1,186,000 | +3.9% | 16,194 | -19.6% | 0.01% | 0.0% |
Q4 2018 | $1,142,000 | -26.5% | 20,150 | +0.0% | 0.01% | -11.1% |
Q3 2018 | $1,554,000 | +16.1% | 20,148 | -0.1% | 0.01% | 0.0% |
Q2 2018 | $1,339,000 | +26.8% | 20,168 | -0.1% | 0.01% | +28.6% |
Q1 2018 | $1,056,000 | -5.9% | 20,183 | -3.8% | 0.01% | 0.0% |
Q4 2017 | $1,122,000 | +1.3% | 20,979 | +3.0% | 0.01% | -12.5% |
Q3 2017 | $1,108,000 | +5.1% | 20,370 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $1,054,000 | -17.8% | 20,370 | -0.2% | 0.01% | -20.0% |
Q1 2017 | $1,283,000 | +14.1% | 20,411 | -4.2% | 0.01% | +11.1% |
Q4 2016 | $1,124,000 | -9.9% | 21,305 | -7.7% | 0.01% | -10.0% |
Q3 2016 | $1,247,000 | +24.3% | 23,089 | -7.0% | 0.01% | +25.0% |
Q2 2016 | $1,003,000 | +5.0% | 24,830 | -8.8% | 0.01% | 0.0% |
Q1 2016 | $955,000 | -21.8% | 27,228 | -0.0% | 0.01% | -20.0% |
Q4 2015 | $1,222,000 | +18.0% | 27,234 | +1.4% | 0.01% | +11.1% |
Q3 2015 | $1,036,000 | -20.4% | 26,867 | -0.1% | 0.01% | -18.2% |
Q2 2015 | $1,302,000 | +19.8% | 26,900 | -12.5% | 0.01% | +22.2% |
Q1 2015 | $1,087,000 | +10.4% | 30,747 | +0.3% | 0.01% | +12.5% |
Q4 2014 | $985,000 | -13.7% | 30,666 | -0.2% | 0.01% | -20.0% |
Q3 2014 | $1,142,000 | -9.6% | 30,721 | -6.9% | 0.01% | -9.1% |
Q2 2014 | $1,263,000 | -16.1% | 33,011 | -0.1% | 0.01% | -15.4% |
Q1 2014 | $1,505,000 | +14.2% | 33,029 | -0.0% | 0.01% | +18.2% |
Q4 2013 | $1,318,000 | -8.9% | 33,041 | +0.2% | 0.01% | -15.4% |
Q3 2013 | $1,446,000 | +54.8% | 32,984 | +11.1% | 0.01% | +44.4% |
Q2 2013 | $934,000 | – | 29,691 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |